$FRGT Balance Sheet | Understand Stock

$FRGT

$1.16 +$0.16 (16.0%) Close

$FRGT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q4 FY2017 As of Dec 31, 2017
ASSETS:
Current assets:
Cash and cash equivalents
Restricted cash in escrow
Accounts receivable, net
Other receivables
Loans to third parties, net
Prepayments
Deferred offering cost
Advance for investment
Related party receivables
Unbilled receivables
Prepaid expenses and other current assets
Total current assets

Capitalized software, net
Property and equipment, net
Long-term office rental deposit
Long-term prepayment
Other long-term assets
Security deposits
Cryptocurrencies
Goodwill
Deferred Tax Assets
Intangible assets, net
Cryptocurrency
Total assets

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT):
Current liabilities:
Accrued payroll
Accounts payable
Advance from customers
Other payables and accruals
Due to related party
Accrued expenses
Short term borrowings
Notes payable, net
Convertible notes payable, net
Warrant liabilities
Convertible debt
Income tax payable
Insurance financing payable
Total current liabilities

Deferred tax liabilities
Provision of other liabilities
Notes payable
Convertible notes payable
Derivative liability, at fair value
Total liabilities
STOCKHOLDERS’ EQUITY (DEFICIT)
Preferred stock, value
Series A Preferred Stock
Series B Preferred Stock
Series C Preferred Stock
Ordinary shares, no par value, (**) unlimited shares authorized; 1,660,627 and 109,255 shares and outstanding at December 31, 2025 and 2024, respectively No
Additional paid in capital
Statutory reserve
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive (loss)
Total stockholders’ equity (deficit)

Total liabilities and stockholders’ equity (deficit)

Comments